SEMIZLIK BILAN OG‘RIGAN BEMORLARDA LIMFOSTAZNING OLDINI OLISH: ZAMONAVIY TAVSIYALAR VA KLINIK AMALIYOT
##article.subject##:
Limfedema, semizlik, profilaktika, limfa tizimi disfunksiyasi, klinik tavsiyalar, ko‘p tarmoqli yondashuv##article.abstract##
Limfedema — bu surunkali, asta-sekin rivojlanadigan kasallik bo‘lib, limfa oqimining buzilishi natijasida to‘qimalarda shish, fibroz va funksional buzilishlar yuzaga keladi. Semizlik limfedemaning birlamchi va ikkilamchi turlarining eng muhim xavf omillaridan biri sifatida tan olingan bo‘lib, uning paydo bo‘lishi, og‘irligi va davolash natijalariga sezilarli ta’sir ko‘rsatadi. Dunyo bo‘yicha semizlikning ortishi limfa tizimi kasalliklarining oldini olish strategiyalariga va dalillarga asoslangan boshqaruv usullariga bo‘lgan e’tiborni kuchaytirdi. Ushbu maqolada semizlik va limfedema o‘rtasidagi patofiziologik bog‘liqlikning zamonaviy tushunchalari tahlil qilinadi, profilaktika bo‘yicha klinik tavsiyalar umumlashtiriladi hamda erta aniqlash, turmush tarzini o‘zgartirish va ko‘p tarmoqli tibbiy yondashuvning amaliy jihatlari yoritiladi.
Библиографические ссылки
International Society of Lymphology. (2023). *The Diagnosis and Treatment of Peripheral Lymphedema: 2023 Consensus Document.*
Wounds International. (2022). *Best Practice for the Management of Lymphedema: Update 2022.* London: Wounds International.
National Institute for Health and Care Excellence (NICE). (2019). *Chronic Venous Disease: Diagnosis and Management (NG89).* London: NICE.
Greene, A. K., & Slavin, S. A. (2021). Obesity-induced lymphedema: Clinical and pathophysiologic insights. *Plastic and Reconstructive Surgery*, 148(5), 923–934.
Zaleska, M., Olszewski, W. L., & Cwikła, J. (2020). The impact of obesity on lymphatic system function: Mechanisms and management. *Lymphatic Research and Biology*, 18(4), 278–286.
Rockson, S. G. (2022). Advances in lymphatic science: Implications for clinical management. *Nature Reviews Cardiology*, 19(9), 623–639.
Centers for Disease Control and Prevention. (2021). *Obesity Prevention Strategies: 2021–2024 Framework.* Atlanta, GA: U.S. Department of Health and Human Services.
British Lymphology Society. (2020). *Consensus Document on the Management of Chronic Edema in Obesity.*
Shimizu, Y., & Mihara, M. (2021). Lymphatic dysfunction in obesity: New insights from imaging and microsurgery. *Annals of Plastic Surgery*, 87(2), 135–143.
European Lymphedema Framework. (2022). *Position Paper: Lymphedema Prevention in Obese Populations.* Brussels: ELF.
